Snakebite in tropical Australia, Papua New Guinea and Irian Jaya

Emergency Medicine

Volumn 12, Issue 4, 2000, Pages 285-294

  Currie, Bart J ^a,b,c  

^a FLINDERS UNIVERSITY   (Australia)

^b Tropical Medicine and International Health Unit   (Australia)

^c Department of Medicine ^*  (Australia)

Author keywords

Australia; Papua New Guinea; Snake venoms; Snakebites

Indexed keywords

CHOLINERGIC RECEPTOR; HAEMORRHAGIN; MYOTOXIN; NEUROTOXIN; SNAKE VENOM; TAIPOXIN; TEXTILOTOXIN; UNCLASSIFIED DRUG;

AUSTRALIA; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG POTENCY; GEOGRAPHIC DISTRIBUTION; HUMAN; MORBIDITY; PAPUA NEW GUINEA; PARALYSIS; PRIORITY JOURNAL; REVIEW; SNAKEBITE;

EID: 0033635873     PISSN: 10356851     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2026.2000.00150.x     Document Type: Review

References (69)

1. Snakebite deaths in Australia 1992-94 and a management update
2. Envenoming and antivenom use in Australia
3. Antivenom use in Australia. Premedication, adverse reactions and the use of venom detection kits
4. Ecology of highly venomous snakes: The Australian genus Oxyuranus (Elapidae)
5. An epidemiological study of snake bite envenomation in Papua New Guinea
6. Snake bite in practice
7. Snake bite in children: A five year population study from South-East Queensland
8. An epidemiological and clinical study of snake-bites in childhood
9. The epidemiology of snakebite in Central Province and National Capital District, Papua New Guinea
10. The importance of bites by the saw-scaled or Carpet Viper (Echis carinatus): Epidemiological studies in Nigeria and a review of the world literature
11. Snake-bites: Appraisal of the global situation
12. Admissions for suspected snake bite to the Perth adult teaching hospitals. 1979-88
13. The taipan (Oxyuranus scutellatus) and the effect of its bite
14. A case of snake-bite treated by specific antivenene
15. Envenoming from the Papuan taipan (Oxyuranus scutellatus canni)
16. Snakebites by the Papuan taipan (Oxyuranus scutellatus canni); paralysis, haemostatic and electrocardiographic abnormalities and effects of antivenom
17. Medicine in tropical Australia: The quality and price of snake antivenoms
18. The top end prospective snakebite study and unresolved issues for Australia and Papua New Guinea
19. A prospective study of snakebite in tropical Australia
20. Neurotoxicity, anticoagulant activity and evidence of rhabdomyolysis in patients bitten by death adders (Acanthophis sp.) in southern Papua New Guinea
21. The Death adder (Acanthophis antarcticus): The effect of the bite and its treatment
22. Clinical toxicology of snakebite in Australia and New Guinea
23. Structure-function properties of venom components from Australian elapids
24. Myotoxic activity of the crude venom and the principal neurotoxin, taipoxin, of the Australian taipan, Oxyuranus scutellatus
25. Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom
26. Studies on Australian snake venoms. Part 1: The haemodynamic effects of brown snake (Pseudonaja) species in the dog
27. The cardiovascular and haematological effects of purified prothrombin activator from the common brown snake (Pseudonaja textilis) and their antagonism with heparin
28. Proteins isolated from the venom of the common tiger snake (Notechis scutatus scutatus) promote hypotension and hemorrhage
29. Taipoxin, an extremely potent presynaptic neurotoxin from the venom of the Australian snake Taipan (Oxyuranus scutellatus scutellatus)
30. The presynaptic neuromuscular blocking agent and phospholipase A2 activity of textilotoxin, a potent toxin isolated from the venom of the Australian brown snake Pseudonaja textilis
31. The effects of taipoxin and notexin on the function and fine structure of the murine neuromuscular junction
32. Isolation and partial characterisation of a lethal neurotoxin from the venom of the Australian Death adder (Acanthophis antarcticus)
33. The present position of snake bite and the snake bitten in Australia
34. The symptomatology and treatment of the bites of Australian snakes
35. The treatment of snakebite
36. Treatment of snakebite
37. The rough-scaled snake (Tropidechis carinatus) a dangerously venomous Australian snake
38. Three instructive cases of tiger snake (Notechis scutatus) envenomation and how a radioimmunoassay proved the diagnosis
39. Ten years of snake bite in Madang Province, Papua New Guinea
40. The small-eyed snake (Micropechis ikaheka): A review of current knowledge
41. The emerging syndrome of envenoming by the New Guinea small-eyed snake Micropechis ikaheka
42. Ten years of snake bites at Fremantle Hospital
43. A review of snakebites and suspected snakebites treated in South Australia with particular reference to reptile handlers
44. Diagnosis and treatment of confirmed and suspected snake bite. Implications from an analysis of 46 paediatric cases
45. Suspected snakebite in children: A study of 156 patients over 10 years
46. Studies on the subunit structure of textilotoxin, a potent neurotoxin from the venom of the Australian common brown snake (Pseudonaja textilis)
47. Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria
48. Progress in clinical toxicology: From case reports to toxicoepidemiology
49. Lymphatic flow rates and first-aid in simulated peripheral snake or spider envenomation
50. Local compression pads as a first-aid measure for victims of bites by Russell's viper (Daboia russelii siamensis) in Myanmar
51. Fatal intracranial haematomas in two patients with brown snake envenomation
52. Low dose subcutaneous adrenaline to prevent acute adverse reactions to antivenom serum in people bitten by snakes: Randomised, placebo controlled trial
53. Antivenoms: Use and adverse reactions over a 12 month period in Australia and Papua New Guinea
54. Premedication for snake antivenom
55. Therapeutic controversies in the management of acute anaphylaxis
56. Brown snakes (Pseudonaja Genus): Venom yields, prothrombin activator neutralization and implications affecting antivenom usage
57. The efficacy of antivenom in prevention of cardiovascular depression and coagulopathy induced by brown snake (Pseudonaja) species venom
58. Efficacy and potency of antivenoms in neutralizing the procoagulant effects of Australian snake venoms in dog and human plasma
59. The efficacy of antivenom in the treatment of bites by the Papuan taipan (Oxyuranus scutellatus canni)
60. Severe envenomation by the taipan (Oxyuranus scutellatus)
61. Use of enzyme immunoassays to compare the effect and assess the dosage regimens of three Brazilian Bothrops antivenoms
62. Randomized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in Sao Paulo, Brazil
63. A randomized 'blinded' comparison of two doses of antivenom in the treatment of Bothrops envenoming in Sao Paulo, Brazil
64. First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: Randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom
65. Resolution of neurotoxicity with anticholinesterase therapy in death-adder envenomation